[1] | Vaziri ND. Dyslipidemia of chronic renal failure: The nature, mechanisms and potential consequences. Am J Physiol, Renal Physiol. 2006; 290: 262-272. |
|
[2] | Vaziri ND. Oxidative stress in chronic renal failure: The nature, mechanism and consequences. Semin Nephrol. 2004; 24: 469-473. |
|
[3] | Gleissner CA, Leitinger N, Ley K. Effects of native and modified low-density lipoproteins on monocyte recruitment in atherosclerosis. Hypertension. 2007; 50: 276-283. |
|
[4] | Hansson GK, Robertson AK, Söderberg-Nauclér C. Inflammation and atherosclerosis. Annu Rev Pathol. 2006; 1: 297-329. |
|
[5] | Davidson MH, Toth PP. High-density lipoprotein metabolism: potential therapeutic targets. Am J Cardio. 2007; 100: n32-n40. |
|
[6] | Feig JE, Shamir R, Fisher EA. Atheroprotective effects of HDL: beyond reverse cholesterol transport. Curr Drug Targets. 2008; 9: 196-203. |
|
[7] | Vaziri ND, Navab M, Fogelman AM. HDL metabolism and activity in chronic kidney disease. Nat Rev Nephrol. 2010; 6: 287-296. |
|
[8] | Kalantar-Zadeh K, Kopple JD, Kamranpour N, et al. HDL-inflammatory index correlates with poor outcome in hemodialysis patients. Kidney Int. 2007; 72: 1149-1156. |
|
[9] | Chauveau P, Nguyen H, Combe C, Chêne G, Azar R, Cano N, Canaud B, Fouque D, Laville M, Leverve X, Roth H, Aparicio M; French Study Group for Nutrition in Dialysis.Dialyzer membrane permeability and survival in hemodialysis patients. Am J Kidney Dis. 2005; 45 (3): 565-71. |
|
[10] | Daugirdas JT. Second generation logarithmic estimates of single-pool variable volume Kt/V: an analysis of error. J Am Soc Nephrol 1993; 4: 1205-1213. |
|
[11] | Dugirdas JT: Simplified equations for monitoring Kt/V, PCRn, eKt/V, and ePCRn. Adv Ren Replace Ther 1995; 2: 295-304. |
|
[12] | Moradi H, Yuan J, Ni Z, et al. Reverse cholesterol pathway in experimental chronic kidney disease. Am J Nephrol. 2009; 30: 147-154. |
|
[13] | Kim C, Vaziri ND. Downregulation of hepatic LDL receptor-related protein (LRP) in chronic renal failure. Kidney Int. 2005; 67: 1028-1032. |
|
[14] | Vaziri ND, Liang K. Down regulation of VLDL receptor expression in chronic experimental renal failure. Kidney Int. 1997; 51: 913-919. |
|
[15] | Moradi H, Pahl MV, Elahimehr R, et al. Impaired Antioxidant Activity of HDL in Chronic Kidney Disease. Transl Res. 2009; 153: 77-85. |
|
[16] | Vaziri ND, Liang K. ACAT inhibition reverses LCAT deficiency and improves plasma HDL in chronic renal failure. Am J Physiol, Renal Physiol. 2004; 287: F1038-F1043. |
|
[17] | Price SR, Du JD, Bailey JL, Mitch WE: Molecular mechanisms regulating protein turnover in muscle. Am J Kidney Dis 2001; 37: S112-S114. |
|
[18] | London GM, Drueke TB. Atherosclerosis and arteriosclerosis in chronic renal failure Kidney Int. 1997; 51 (6): 1678-95. |
|
[19] | Okuno S, Ishimura E, Kohno K, Fujino-Katoh Y, Maeno Y, Yamakawa T, Inaba M, Nishizawa Y. Serum beta2-microglobulin level is a significant predictor of mortality in maintenance haemodialysis patients. Nephrol Dial Transplant 2009; 24 (2): 571-7. |
|
[20] | Wilson AM, Kimura E, Harada RK, Nair N, Narasimhan B, Meng XY, Zhang F, Beck KR, Olin JW, Fung ET, Cooke JP. Beta2-microglobulin as a biomarker in peripheral arterial disease: proteomic profiling and clinical studies. Circulation 2007; 116: 1396-1403. |
|
[21] | R.Barazzoni, G.Biolo, M.Zanetti, A.Bernardi, G.Guarnieri. Inflammation and Adipose Tissue in Uremia. J of Renal Nutrition 2006; 16 (3): 204-207. |
|
[22] | Burl R Don, Laura M Rosales, Nathan W Levine, William Mitch and George A Kaysen. Leptin is a negative acute phase protein in chronic hemodialysis patients. Kidney Intl 2001; 59: 1114-1120. |
|
[23] | Vaziri ND, Moradi H, Pahl MV, et al. In vitro stimulation of HDL anti-inflammatory activity and inhibition of LDL pro-inflammatory activity in the plasma of patients with end-stage renal disease by an apoA-1 mimetic peptide. Kidney Int. 2009; 76: 437-44. |
|
[24] | Van Lenten BJ, Reddy ST, Navab M, et al. Understanding changes in high density lipoproteins during the acute phase response. Arterioscler Thromb Vasc Biol. 2006; 26: 1687-1688. |
|
[25] | Sonikian M, Gogusev J, Zingraff J, et al: Potential effect of metabolic acidosis on beta2-microglobulin generation: in vivo and in vitro studies. J Am Soc Nephrol 1996; 7: 350-356. |
|
[26] | Gugliucci A, Mehlhaff K, Kinugasa E, et al. Paraoxonase-1 concentrations in end-stage renal disease patients increase after hemodialysis: correlations with low molecular AGE adduct clearance. Clin Chim Acta. 2007; 377: 213-220. |
|
[27] | Albertini R, Rindi S, Passi A, et al. The effect of heparin on Cu (2+)-mediated oxidation of human low-density lipoproteins. FEBS Lett. 1995; 377 (2): 240-242. |
|
[28] | Sandström J, Carlsson L, Marklund SL, et al. The heparin-binding domain of extracellular superoxide dismutase C and formation of variants with reduced heparin affinity. J Biol Chem. 1992; 267: 8205-18209. |
|